Partner Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 187

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $60M

  • Investors
  • 3

Partner Therapeutics General Information

Description

Developer of a biopharmaceutical company designed to assist in oncology treatment. The company's drugs are developed focusing on developing and commercializing approved and late-stage therapies that improve treatment outcomes and reduce the total cost of care for cancer, enabling patients to get effective oncology treatments for any stage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 19 Muzzey Street
  • Lexington, MA 02421
  • United States
+1 (781)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 19 Muzzey Street
  • Lexington, MA 02421
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Partner Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 01-Feb-2018 $60M Completed Generating Revenue
To view Partner Therapeutics’s complete valuation and funding history, request access »

Partner Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Partner Therapeutics’s complete cap table history, request access »

Partner Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biopharmaceutical company designed to assist in oncology treatment. The company's drugs are developed foc
Drug Discovery
Lexington, MA
187 As of 2026

Shelton, CT
 

Cerdanyola, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Partner Therapeutics Competitors (117)

One of Partner Therapeutics’s 117 competitors is Nanoviricides, a Corporation company based in Shelton, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nanoviricides Corporation Shelton, CT
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Palobiofarma Venture Capital-Backed Barcelona, Spain
Day One Biopharmaceuticals Formerly VC-backed Brisbane, CA
Genentech Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 117 competitors. Get the full list »

Partner Therapeutics Patents

Partner Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4784160-A2 Effects of gm-csf addition on humoral modulation and fcgr2b binding in allergy, infection and immunity Pending 29-Sep-2023
WO-2025072659-A2 Effects of gm-csf addition on humoral modulation and fcgr2b binding in allergy, infection and immunity Inactive 29-Sep-2023
WO-2025072659-A3 Effects of gm-csf addition on humoral modulation and fcgr2b binding in allergy, infection and immunity Inactive 29-Sep-2023
EP-4704881-A2 Humoral modulation in vaccinated and virally infected subjects with granulocyte-macrophage colony-stimulating factor (gm-csf) Pending 03-May-2023
US-20260295009-A1 Humoral modulation in vaccinated and virally infected subjects with granulocyte-macrophage colony-stimulating factor (gm-csf) Pending 03-May-2023 A61K38/193
To view Partner Therapeutics’s complete patent history, request access »

Partner Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Partner Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adams Street Partners PE/Buyout Minority
MidCap Financial Lender/Debt Provider Minority
Perceptive Advisors Venture Capital Minority
To view Partner Therapeutics’s complete investors history, request access »

Partner Therapeutics Investments (1)

Partner Therapeutics’s most recent deal was a Corporate Asset Purchase with Immunex (Global rights to Leukine). The deal was made on 01-Feb-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Immunex (Global rights to Leukine) 01-Feb-2018 Corporate Asset Purchase Buildings and Property
To view Partner Therapeutics’s complete investments history, request access »

Partner Therapeutics FAQs

  • When was Partner Therapeutics founded?

    Partner Therapeutics was founded in 2017.

  • Where is Partner Therapeutics headquartered?

    Partner Therapeutics is headquartered in Lexington, MA.

  • What is the size of Partner Therapeutics?

    Partner Therapeutics has 187 total employees.

  • What industry is Partner Therapeutics in?

    Partner Therapeutics’s primary industry is Drug Discovery.

  • Is Partner Therapeutics a private or public company?

    Partner Therapeutics is a Private company.

  • What is the current valuation of Partner Therapeutics?

    The current valuation of Partner Therapeutics is .

  • What is Partner Therapeutics’s current revenue?

    The current revenue for Partner Therapeutics is .

  • How much funding has Partner Therapeutics raised over time?

    Partner Therapeutics has raised $60M.

  • Who are Partner Therapeutics’s investors?

    Adams Street Partners, MidCap Financial, and Perceptive Advisors have invested in Partner Therapeutics.

  • Who are Partner Therapeutics’s competitors?

    Nanoviricides, Ability Pharma, Palobiofarma, Day One Biopharmaceuticals, and Genentech are some of the 117 competitors of Partner Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process